MyFinsight
Home
Blog
About
Contact
Proceeds from issuance of
common stock under sepa
$413K
Net cash provided by
(used in) financing...
$110K
Canceled cashflow
$303K
Net decrease in cash
and cash...
-$5,157K
Canceled cashflow
$110K
Accounts payable and
accrued expenses
$3,069K
Stock-based compensation
$956K
Depreciation and
amortization
$120K
Right-of-use assets and lease
liabilities, net
$116K
Payment of financing
costs related to...
$289K
Payments for taxes
related to net...
$14K
Net cash used in
operating activities
-$5,267K
Canceled cashflow
$4,261K
Consolidated net loss and
comprehensive loss
-$6,344K
Change in fair value of
warrant liability
-$2,674K
Change in fair value of
ppas
-$273K
Prepaid expenses and
other assets
$237K
Back
Back
Cash Flow
BioAtla, Inc. (BCAB)
BioAtla, Inc. (BCAB)
source: myfinsight.com